BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8113720)

  • 1. Virulence and pathogenesis of non-virulent and virulent strains of pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus.
    Mulder WA; Priem J; Glazenburg KL; Wagenaar F; Gruys E; Gielkens AL; Pol JM; Kimman TG
    J Gen Virol; 1994 Jan; 75 ( Pt 1)():117-24. PubMed ID: 8113720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Live attenuated pseudorabies virus expressing envelope glycoprotein E1 of hog cholera virus protects swine against both pseudorabies and hog cholera.
    van Zijl M; Wensvoort G; de Kluyver E; Hulst M; van der Gulden H; Gielkens A; Berns A; Moormann R
    J Virol; 1991 May; 65(5):2761-5. PubMed ID: 1850051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-generation pseudorabies virus vaccine with deletions in thymidine kinase and glycoprotein genes.
    Kit S; Sheppard M; Ichimura H; Kit M
    Am J Vet Res; 1987 May; 48(5):780-93. PubMed ID: 3035972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes.
    Marchioli CC; Yancey RJ; Wardley RC; Thomsen DR; Post LE
    Am J Vet Res; 1987 Nov; 48(11):1577-83. PubMed ID: 2829665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a quadruple glycoprotein-deleted pseudorabies virus mutant for use as a biologically safe live virus vaccine.
    Mettenleiter TC; Klupp BG; Weiland F; Visser N
    J Gen Virol; 1994 Jul; 75 ( Pt 7)():1723-33. PubMed ID: 8021601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein gp50-negative pseudorabies virus: a novel approach toward a nonspreading live herpesvirus vaccine.
    Heffner S; Kovács F; Klupp BG; Mettenleiter TC
    J Virol; 1993 Mar; 67(3):1529-37. PubMed ID: 8382308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribonucleotide reductase-deficient mutants of pseudorabies virus are avirulent for pigs and induce partial protective immunity.
    de Wind N; Berns A; Gielkens A; Kimman T
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():351-9. PubMed ID: 8383170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenicity and immunogenicity of a gE/gI/TK gene-deleted pseudorabies virus variant in susceptible animals.
    Cong X; Lei JL; Xia SL; Wang YM; Li Y; Li S; Luo Y; Sun Y; Qiu HJ
    Vet Microbiol; 2016 Jan; 182():170-7. PubMed ID: 26711045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of glycoprotein gE and thymidine kinase or the US3-encoded protein kinase synergistically decreases in vivo replication of pseudorabies virus and the induction of protective immunity.
    Kimman TG; De Wind N; De Bruin T; de Visser Y; Voermans J
    Virology; 1994 Dec; 205(2):511-8. PubMed ID: 7975253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the protective efficacy of recombinant pseudorabies viruses against pseudorabies and classical swine fever in pigs; influence of different promoters on gene expression and on protection.
    Hooft van Iddekinge BJ; de Wind N; Wensvoort G; Kimman TG; Gielkens AL; Moormann RJ
    Vaccine; 1996 Jan; 14(1):6-12. PubMed ID: 8821642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody response to glycoprotein I in maternally immune pigs exposed to a mildly virulent strain of pseudorabies virus.
    van Oirschot JT; Daus F; Kimman TG; van Zaane D
    Am J Vet Res; 1991 Nov; 52(11):1788-93. PubMed ID: 1664670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission of two pseudorabies virus strains that differ in virulence and virus excretion in groups of vaccinated pigs.
    Bouma A; De Jong MC; Kimman TG
    Am J Vet Res; 1996 Jan; 57(1):43-7. PubMed ID: 8720236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoprotein I of pseudorabies virus (Aujeszky's disease virus) determines virulence and facilitates penetration of the virus into the central nervous system of pigs.
    Jacobs L; Mulder WA; Priem J; Pol JM; Kimman TG
    Acta Vet Hung; 1994; 42(2-3):289-300. PubMed ID: 7810422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deleting valine-125 and cysteine-126 in glycoprotein gI of pseudorabies virus strain NIA-3 decreases plaque size and reduces virulence in mice.
    Jacobs L; Rziha HJ; Kimman TG; Gielkens AL; Van Oirschot JT
    Arch Virol; 1993; 131(3-4):251-64. PubMed ID: 8394068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated properties of thymidine kinase-negative deletion mutant of pseudorabies virus.
    Kit S; Kit M; Pirtle EC
    Am J Vet Res; 1985 Jun; 46(6):1359-67. PubMed ID: 2992322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic recombination of pseudorabies virus: evidence that homologous recombination between insert sequences is less frequent than between autologous sequences.
    Glazenburg KL; Moormann RJ; Kimman TG; Gielkens AL; Peeters BP
    Arch Virol; 1995; 140(4):671-85. PubMed ID: 7794111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative study of pseudorabies virus (PRV) strains with defects in thymidine kinase and glycoprotein genes.
    Ferrari M; Mettenleiter TC; Romanelli MG; Cabassi E; Corradi A; Dal Mas N; Silini R
    J Comp Pathol; 2000; 123(2-3):152-63. PubMed ID: 11032669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudorabies virus glycoprotein gIII is a major target antigen for murine and swine virus-specific cytotoxic T lymphocytes.
    Zuckermann FA; Zsak L; Mettenleiter TC; Ben-Porat T
    J Virol; 1990 Feb; 64(2):802-12. PubMed ID: 2153244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deleting two amino acids in glycoprotein gI of pseudorabies virus decreases virulence and neurotropism for pigs, but does not affect immunogenicity.
    Jacobs L; Mulder WA; Van Oirschot JT; Gielkens AL; Kimman TG
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2201-6. PubMed ID: 8409943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudorabies virus expressing bovine herpesvirus 1 glycoprotein B exhibits altered neurotropism and increased neurovirulence.
    Gerdts V; Beyer J; Lomniczi B; Mettenleiter TC
    J Virol; 2000 Jan; 74(2):817-27. PubMed ID: 10623744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.